Serum erythropoietin titers in hematological malignancies and related diseases.
暂无分享,去创建一个
K. Mitani | F. Takaku | K. Yoshinaga | A. Urabe | M. Yagisawa | Y. Ohbayashi | S. Iki
[1] D. Ettinger,et al. Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. , 1992, Journal of the National Cancer Institute.
[2] M. Goldberg,et al. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. , 1990, Blood.
[3] S. Piantadosi,et al. Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.
[4] H. Gisslinger,et al. Erythropoietin treatment of anemia associated with multiple myeloma. , 1990, The New England journal of medicine.
[5] S. Lewis,et al. Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. , 1986, The New England journal of medicine.
[6] R. Abels. Recombinant human erythropoietin in the treatment of the anaemia of cancer. , 1992, Acta haematologica.
[7] J. Adamson,et al. Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. , 1992, Acta haematologica.
[8] M. Arning,et al. Serum erythropoietin concentrations in patients with myelodysplastic syndromes. , 1991, Leukemia research.
[9] F. Takaku,et al. Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. , 1987, International journal of cell cloning.
[10] H. Koeffler,et al. Erythropoietin radioimmunoassay in evaluating patients with polycythemia. , 1981, Annals of internal medicine.